Every Form 4 that Piper Sandler Companies (PIPR) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow PIPR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PIPR filings page.
Piper Sandler Companies executive James P. Baker reported equity compensation activity in company stock. He received a grant of 2,364 shares of common stock at no cost. On the same date, 211, 215, and 113 shares were delivered to cover tax withholding obligations, treated as dispositions rather than open-market sales.
After these transactions, Baker directly held 61,692 Piper Sandler common shares. In addition, 25,699 shares are held in an irrevocable trust for his spouse, for which he disclaims beneficial ownership, and 25,699 shares are held in an irrevocable trust for his benefit, both reported as indirect holdings.
Piper Sandler Companies CEO and Chairman Chad R. Abraham reported equity award activity in company common stock. He received a grant of 4,985 shares at no cost, increasing his directly held stake.
On the same date, he had three tax-withholding dispositions of 1,080, 689 and 459 shares to satisfy tax obligations tied to awards, leaving 56,315 shares held directly. He also has 36,000 shares held indirectly through a revocable living trust where he and his spouse serve as trustees and he is a beneficiary.
Piper Sandler Companies’ President Debbra L. Schoneman reported an option exercise and related stock sales. On February 11, 2026, she exercised an employee stock option for 5,240 shares of common stock at $99 per share. The exercise increased her direct common stock holdings before subsequent sales.
That same day, she sold 81 shares of common stock at a weighted average price of $350.03, and separately sold 5,159 shares at $351.01 in open-market transactions. Following these trades, she directly owned 2,896 shares and indirectly held 56,264 shares through revocable living trusts for which she and her spouse serve as co‑trustees.
Piper Sandler Companies director reports stock award. Director Stuart Essig reported receiving 175 shares of Piper Sandler Companies common stock on February 4, 2026. The shares were acquired at a price of $0 per share, bringing his directly held beneficial ownership to 175 common shares after the transaction.
Piper Sandler Companies director defers fees into stock units
A director of Piper Sandler Companies reported a routine compensation-related transaction. On 12/31/2025, the director accrued 75 shares of phantom stock at a price of $0 by electing to defer quarterly director cash retainer fees into stock-based units instead of taking cash. After this transaction, the director beneficially owned 25,525 shares of Piper Sandler common stock in total on a direct basis.
The phantom stock will be paid out in Piper Sandler common shares on the last day of the year in which the director’s board service ends, aligning part of the director’s compensation with the company’s long-term share performance.
Piper Sandler Companies director Philip E. Soran reported a routine change in his holdings. On 12/31/2025, he acquired 75 shares of phantom stock at a price of $0, reflecting his election to defer quarterly director cash retainer fees.
After this transaction, he beneficially owned 19,330 shares of common stock in total. The 75 phantom shares will be paid out in Piper Sandler common stock on the last day of the year in which his service as a director ends.
Piper Sandler Companies director reports deferred-fee stock accrual
A director of Piper Sandler Companies reported a transaction dated 12/31/2025 involving company common stock. The filing shows the director acquired 75 shares of common stock at a price of $0, bringing her total directly owned common shares to 1,349 after the transaction.
According to the explanation, the director elected to defer quarterly director cash retainer fees, which resulted in the accrual of 75 shares of phantom stock to her account. These phantom shares are to be paid out in common stock on the last day of the year in which her service as a director ends.
Piper Sandler Companies director reported an insider equity transaction involving the company’s common stock. On 12/12/2025, the director acquired 6 additional shares at a price of $ 0 per share, bringing total beneficial ownership to 25,450 shares held directly.
The filing explains that dividend equivalents paid on shares of phantom stock in the directors' deferred compensation plan are deemed reinvested in additional phantom shares. These phantom stock amounts become payable in an equal number of shares of common stock on the last day of the year in which the director’s service as a board member terminates.
Piper Sandler Companies director Philip E. Soran reported an automatic acquisition of 38 shares of common stock on 12/12/2025 at a price of $0 per share, bringing his directly held stake to 19,255 shares. The filing explains that dividend equivalents paid on phantom stock are reinvested into additional phantom shares under the directors' deferred compensation plan, which become payable in an equal number of common shares on the last day of the year in which his service as a director ends.
Piper Sandler Companies director Scott C. Taylor received 16 shares of common stock on 12/12/2025 through a deferred compensation plan transaction at a price of $0.
The filing shows his beneficial ownership rising to 16,352 common shares held directly. The additional shares reflect dividend equivalents on phantom stock that are automatically reinvested in more phantom shares.
According to the plan, these phantom shares become payable in an equal number of common shares on the last day of the year in which his service as a director ends.
Piper Sandler Companies disclosed an insider equity transaction by a director tied to the company’s deferred compensation plan. On 12/12/2025, 7 shares of phantom stock were credited as dividend equivalents, which are designed to be reinvested and track the value of common stock.
These phantom shares accrue in the director’s deferred compensation account and will be settled in an equal number of common shares when the director’s board service ends. Following this transaction, the reporting person beneficially owned 3,391 shares of common stock directly.
Piper Sandler Companies director Victoria M. Holt reported acquiring 14 shares of common stock on December 12, 2025 at a price of $0. After this transaction, she beneficially owns 7,339 shares of Piper Sandler common stock in direct form. The filing explains that dividend equivalents paid on shares of phantom stock are automatically reinvested into additional phantom shares in the directors' deferred compensation plan, and these phantom shares are ultimately payable in an equal number of common shares after the year in which the director’s board service ends.
Piper Sandler Companies director Ann C. Gallo reported a small increase in her deferred equity holdings. On 12/12/2025, she acquired 3 additional shares of common stock at a price of $0, credited as dividend equivalents on existing phantom stock.
After this automatic reinvestment, she beneficially owns 1,274 shares, shown as directly held. According to the plan terms, dividend equivalents on phantom stock are reinvested as additional phantom shares in the directors' deferred compensation plan, and those phantom shares will be paid out in an equal number of common shares on the last day of the year in which her service as a director ends.
Piper Sandler Companies CEO and Chairman reported several stock transactions involving company common stock. On 11/26/2025, he exercised 4,400 employee stock options at an exercise price of $99 per share and sold blocks of common stock in multiple trades at weighted average prices around $336–$339. On 11/28/2025, he exercised an additional 3,000 employee stock options at $99 and sold shares at weighted average prices around $335–$337.
After these transactions, he held 53,558 shares of common stock directly and 36,000 shares indirectly through a revocable living trust. He also held 15,600 employee stock options (right to buy) following the reported exercises.
Piper Sandler Companies reported an insider stock sale by its Chief Financial Officer. On 11/21/2025, the CFO disposed of 1,367 shares of Piper Sandler common stock in an open market transaction coded as a sale. The shares were sold at a weighted average price of $324.69, with individual sale prices ranging from $324.6806 to $324.9700.
After this transaction, the reporting person beneficially owned 10,425 shares of Piper Sandler common stock, held directly. The filing notes that detailed breakdowns of the number of shares sold at each price within the reported range are available upon request to the company, the SEC staff, or any shareholder.
Piper Sandler Companies (PIPR) director reported a small sale of company stock. On 11/18/2025, the reporting person sold 598 shares of common stock in an open-market transaction coded "S" (sale). The weighted average sale price was $317.05 per share, with individual trades executed between $317.04 and $317.16.
After this transaction, the director beneficially owns 19,217 shares of Piper Sandler common stock in direct form. The sale was executed under standard reporting rules for insiders and reflects a routine change in the director’s personal holdings rather than an operational change at the company.
Piper Sandler Companies reported an insider equity transaction by its Chief Financial Officer. On 11/14/2025, the CFO disposed of 1,464 shares of common stock in a transaction coded "F" at a price of $0 per share, typically indicating shares withheld to cover taxes on a prior equity award. Following this transaction, the CFO directly beneficially owned 11,792 shares of Piper Sandler common stock.
Piper Sandler Companies (PIPR): President Debbra L. Schoneman reported insider transactions on 11/05/2025. She exercised 2,500 employee stock options at an exercise price of $99 per share, then sold portions of common stock in multiple trades at weighted-average prices.
Reported sales included 700 shares at $328.68, 443 shares at $330.09, 1,237 shares at $331.19, and 120 shares at $331.98. Following these transactions, she directly held 2,896 common shares. In addition, 56,264 common shares are held indirectly through revocable living trusts where she and her spouse serve as co-trustees. After the exercise, 15,167 derivative (option) securities remained beneficially owned.